New Releases from NCBI BookshelfBimekizumab (Bimzelx): CADTH Reimbursement Review: Therapeutic area: Psoriasis, moderate to severe plaque [Internet].Bimekizumab (Bimzelx): CADTH Reimbursement Review: Therapeutic area: Psoriasis, moderate to severe plaque [Internet].